117 related articles for article (PubMed ID: 37549754)
21. Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles.
Ibrahim KM; Mantawy EM; Elanany MM; Abdelgawad HS; Khalifa NM; Hussien RH; El-Agroudy NN; El-Demerdash E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):739-748. PubMed ID: 31853613
[TBL] [Abstract][Full Text] [Related]
22. Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats.
Abdelrahman AM; Al Suleimani YM; Manoj P; Ashique M; Ali BH; Schupp N
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jan; 393(1):121-130. PubMed ID: 31501914
[TBL] [Abstract][Full Text] [Related]
23. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity.
El-Moselhy MA; El-Sheikh AA
Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999
[TBL] [Abstract][Full Text] [Related]
24. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
[TBL] [Abstract][Full Text] [Related]
26. Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction.
Lin YW; Chen CY; Shih JY; Cheng BC; Chang CP; Lin MT; Ho CH; Chen ZC; Fisch S; Chang WT
J Am Heart Assoc; 2021 Apr; 10(7):e019274. PubMed ID: 33749310
[TBL] [Abstract][Full Text] [Related]
27. Prevention of Doxorubicin-Induced Renal Toxicity by Theanine in Rats.
Nagai K; Fukuno S; Otani K; Nagamine Y; Omotani S; Hatsuda Y; Myotoku M; Konishi H
Pharmacology; 2018; 101(3-4):219-224. PubMed ID: 29393264
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of proanthocyanidins against doxorubicin-induced nephrotoxicity in rats.
El-Sayed EM; Mansour AM; El-Sawy WS
J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28759702
[TBL] [Abstract][Full Text] [Related]
29. P-Coumaric Acid Mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis.
Rafiee Z; Moaiedi MZ; Gorji AV; Mansouri E
Arch Med Res; 2020 Jan; 51(1):32-40. PubMed ID: 32086107
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.
Rodriguez D; Kapoor S; Edenhofer I; Segerer S; Riwanto M; Kipar A; Yang M; Mei C; Wüthrich RP
Kidney Blood Press Res; 2015; 40(6):638-47. PubMed ID: 26698317
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the multi-targeted protection potential of tannic acid against doxorubicin-induced kidney damage in rats.
Yesilkent EN; Ceylan H
Chem Biol Interact; 2022 Sep; 365():110111. PubMed ID: 35987278
[TBL] [Abstract][Full Text] [Related]
32. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
[TBL] [Abstract][Full Text] [Related]
33. Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy.
Akolkar G; da Silva Dias D; Ayyappan P; Bagchi AK; Jassal DS; Salemi VMC; Irigoyen MC; De Angelis K; Singal PK
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H795-H809. PubMed ID: 28710069
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of epithelial-mesenchymal transition via SGLT2 inhibition and diabetic cataract suppression by dapagliflozin nanoparticles treatment.
Chen YY; Chen CK; Wu TT; Ho CY; Yeh TC; Sun GC; Tseng CJ; Cheng PW
Life Sci; 2023 Oct; 330():122005. PubMed ID: 37549827
[TBL] [Abstract][Full Text] [Related]
35. BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagy.
Zhao XX; Cho H; Lee S; Woo JS; Song MY; Cheng XW; Lee KH; Kim W
Chem Biol Interact; 2020 Sep; 328():109190. PubMed ID: 32652078
[TBL] [Abstract][Full Text] [Related]
36. Dapagliflozin attenuates high glucose-induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation.
Faridvand Y; Kazemzadeh H; Vahedian V; Mirzajanzadeh P; Nejabati HR; Safaie N; Maroufi NF; Pezeshkian M; Nouri M; Jodati A
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):643-651. PubMed ID: 35274762
[TBL] [Abstract][Full Text] [Related]
37. Cardio-protective effect of dapagliflozin against doxorubicin induced cardiomyopathy in rats.
Belen E; Canbolat IP; Yigittürk G; Cetinarslan Ö; Akdeniz CS; Karaca M; Sönmez M; Erbas O
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4403-4408. PubMed ID: 35776041
[TBL] [Abstract][Full Text] [Related]
38. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
[TBL] [Abstract][Full Text] [Related]
39. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.
Kavazis AN; Smuder AJ; Min K; Tümer N; Powers SK
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1515-24. PubMed ID: 20833957
[TBL] [Abstract][Full Text] [Related]
40. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
